Facebook
X
LinkedIn
ForwardNeuroRestorative's 7th Annual Medical Directors Conference 2026
This is an in-person activity.
NeuroRestorative operates neurorehabilitation and residential programs for patients with stroke, brain injury, spinal cord injury, and other neurologic diagnoses. The 7th annual Medical Directors Conference is designed to bring together Medical Directors and other health care team members from across the country to address problems/issues commonly seen among NeuroRestorative patients.
Target Audience
This activity is intended for physicians, nurses, and other members of NeuroRestorative’ s healthcare teams located across the country with specialties in rehabilitation medicine, brain injury rehabilitation, and medically complex comorbidities -- for both adults and pediatric populations.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Summarize the evidence for the chronic effects of brain injury and the efficacy of post-hospital interdisciplinary neurorehabilitation programs.
- Identify psychopharmacologic strategies for managing mood and substance use disorders.
- Describe the spectrum of treatment options for spasticity that can be provided by various rehabilitation team members.
- Describe how artificial intelligence can be used to enhance neurorehabilitation.
- Distinguish awareness, insight, and denial as seen in a neurorehabilitation setting.
- Identify lifestyle approaches to improving cognitive function and preventing cognitive decline with aging.
Additional Information
Spaulding Rehabilitation Hospital, NeuroRestorative & Mass General Brigham
Course summary
- 7.50 AMA PRA Category 1 Credit™
- 7.50 Nursing Contact Hours
- 7.50 Participation
Wednesday, September 23, 2026
| 2:50pm | Announcements & Introductions | Mel Glenn, MD |
| 3:00 | Company Overview & Updates | Jane Imboden |
| 3:30 | Post-Hospital Rehabilitation & the Effect of Compulsory Funding | Gordon Horn, PhD, Frank Lewis, PhD & Mel Glenn, MD |
| 4:20 | The Management of Spasticity | Jennifer Doble, MD |
| 5:10 | Wrap-Up | Mel Glenn, MD |
| 5:30pm | Day 1 Adjournment |
Thursday, September 24, 2026
| 8:00am | Announcements | Mel Glenn, MD |
| 8:10 | Artificial Intelligence in Neurorehabilitation: The Good, the Bad, and the Ugly | James Cotton, MD |
| 9:00 | Managing Psychotropic Medications while Also Treating Mood and Substance Use Disorders | Owen Perlman, MD |
| 9:50 | QI Update | Lu Sutherland, DNP, MSN, RN, PTA |
| 10:20 | Coffee Break |
| 10:40 | Awareness, Insight & Denial in Neurorehabilitation | Joseph Giacino, PhD |
| 11:30 | Applications of Artificial Intelligence to NeuroRestorative Clinical and Research Data | Gordon Horn, PhD |
| 12:30pm | Lunch |
| 1:30 | Lifestyle Choices to Optimize Cognitive Function (For You & Your Patients) | Mel Glenn, MD |
| 2:15 | Wrap-Up | Mel Glenn, MD |
| 2:30pm | Conference Adjournment |
Mel Glenn, MD - Course Director
National Medical Director, NeuroRestorative
Associate Professor of Physical Medicine & Rehabilitation, Harvard Medical School
James Cotton, MD, PHD
Assistant Professor, Department of Physical Medicine & Rehabilitation - Northwestern University
Physician-Scientist & Lab Director, Intelligent Sensing & Rehabilitation - Shirley Ryan AgilityLab
Jennifer Doble, MD
Medical Director, NeuroRestorative - Florida
Joseph Giacino, PhD
Director, Rehabilitation Neuropsychology - Spaulding Rehabilitation Hospital
Consulting Neuropsychologist, Department of Psychiatry - Massachusetts General Hospital
Professor, Department of Physical Medicine & Rehabilitation - Harvard Medical School
Gordon Horn, PhD
Clinical Assistant Professor, Florida State University College of Medicine
National Director of Analytics & Outcomes, NeuroRestorative
Jane Imboden
President, NeuroRestorative
Frank Lewis, PhD
Senior Director of Clinical Outcome Services, NeuroRestorative
Head, Institutional Review Board - NeuroRestorative Research Institute
Adjunct Assistant Professor, Trauma, Surgery & Critical Care - Medical College of Georgia
Owen Perlman, MD
Founding Partner, Associates of Physical Medicine & Rehabilitation (Michigan)
Fellow, American Society of Clinical Pyschopharmacology
Medical Director, NeuroRestorative - Michigan
Lu Sutherland, DNP, MSN, RN, PTA
Chief Nursing Officer & Vice President of Quality Improvement, NeuroRestorative
In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AMA PRA Category 1 CreditsTM
Mass General Brigham designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing
Mass General Brigham designates this activity for 7.50 ANCC contact hours. Nurses should only claim credit commensurate with the extent of their participation in the activity.
Available Credit
- 7.50 AMA PRA Category 1 Credit™
- 7.50 Nursing Contact Hours
- 7.50 Participation